Illumina: The Measurement Monopoly
Description
Summary drafted by a large language model.
Discover the fascinating story of Illumina, a company that transformed the life sciences by establishing a Measurement Monopoly. Founded by an unusual team including a blind venture capitalist, a veterinarian, a Harvard professor, a chemist, and a molecular biologist, Illumina started as a small startup in San Diego and grew to define a new category of biotech. Through fierce competition, innovative technology, and strategic acquisitions, Illumina became the leading provider of DNA sequencing platforms, shaping the future of genomics and personalized medicine.
Read article here, and use the opportunity to browse the Century of Biology blog, which is pretty amazing.
Recently on :
Biotech
Business
WEB - 2023-12-11
AI made from living human brain cells performs speech recognition | NewScientist
NewScientist - Researchers at Indiana University Bloomington have developed a biocomputing system that uses living brain cells ...
WEB - 2023-10-23
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia
Verve Therapeutics, a clinical-stage biotechnology company, announced the lifting of the clinical hold and clearance of its IND...
WEB - 2023-10-10
Novo Nordisk stops Ozempic kidney trial after early signs of success | Reuters
Reuters - Novo Nordisk stops a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because i...
WEB - 2023-09-23
Nvidia Buys Illumina? The AI Foundry for Healthcare | Semianalysis
Semianalysis report on the acquisition of Illumina by Nvidia, and use the opportunity to go through all the opportunities of AI...
WEB - 2023-09-17
Illumina: The Measurement Monopoly
Elliot Hershberg explores the story of Illumina, a company that established a Measurement Monopoly in the life sciences by inve...